Sharp, Andrew ORCID: 0000-0003-3396-7464, Cornforth, Christine, Jackson, Richard, Harrold, Jane
ORCID: 0000-0002-9281-1446, Turner, Mark A
ORCID: 0000-0002-5299-8656, Kenny, Louise
ORCID: 0000-0002-9011-759X, Baker, Philip N, Johnstone, Edward D, Khalil, Asma, von Dadelszen, Peter et al (show 2 more authors)
(2019)
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction.
LANCET CHILD & ADOLESCENT HEALTH, 3 (3).
E2-E3.
This is the latest version of this item.
![]() |
Text
Commentary for Lancet FINAL reviewed and edited clean.docx - Author Accepted Manuscript Download (32kB) |
![]() |
Text
Commentary for Lancet FINAL.docx - Author Accepted Manuscript Download (32kB) |
Official URL: http://dx.doi.org/10.1016/s2352-4642(19)30020-3
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Humans, Fetal Growth Retardation, Pregnancy, Infant, Newborn, Female, Randomized Controlled Trials as Topic, Phosphodiesterase 5 Inhibitors, Sildenafil Citrate, United Kingdom |
Depositing User: | Symplectic Admin |
Date Deposited: | 21 Aug 2020 07:18 |
Last Modified: | 18 Jan 2023 23:39 |
DOI: | 10.1016/S2352-4642(19)30020-3 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3095117 |
Available Versions of this Item
-
Review of mortality from the STRIDER UK trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. (deposited 17 Jan 2019 08:21)
- Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. (deposited 21 Aug 2020 07:18) [Currently Displayed]
Dimensions
Altmetric
Share
CORE (COnnecting REpositories)